RBC Europe’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-478
| Closed | -$8.8K | – | 1077 |
|
2021
Q3 | $8.8K | Hold |
478
| – | – | ﹤0.01% | 960 |
|
2021
Q2 | $6.67K | Hold |
478
| – | – | ﹤0.01% | 1016 |
|
2021
Q1 | $7.04K | Hold |
478
| – | – | ﹤0.01% | 960 |
|
2020
Q4 | $9.27K | Hold |
478
| – | – | ﹤0.01% | 890 |
|
2020
Q3 | $5.33K | Sell |
478
-210
| -31% | -$2.34K | ﹤0.01% | 900 |
|
2020
Q2 | $9.31K | Hold |
688
| – | – | ﹤0.01% | 782 |
|
2020
Q1 | $5.56K | Buy |
688
+90
| +15% | +$727 | ﹤0.01% | 819 |
|
2019
Q4 | $5.75K | Hold |
598
| – | – | ﹤0.01% | 894 |
|
2019
Q3 | $6.34K | Hold |
598
| – | – | ﹤0.01% | 866 |
|
2019
Q2 | $6.88K | Buy |
598
+153
| +34% | +$1.76K | ﹤0.01% | 868 |
|
2019
Q1 | $5.7K | Hold |
445
| – | – | ﹤0.01% | 914 |
|
2018
Q4 | $2.74K | Hold |
445
| – | – | ﹤0.01% | 975 |
|
2018
Q3 | $4.68K | Buy |
+445
| New | +$4.68K | ﹤0.01% | 970 |
|